Hong Kong · Delayed Price · Currency is HKD CStone Pharmaceuticals Statistics
Total Valuation
HKG:2616 has a market cap or net worth of HKD 8.21 billion. The enterprise value is 7.53 billion.
| Market Cap | 8.21B |
| Enterprise Value | 7.53B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2616 has 1.60 billion shares outstanding. The number of shares has increased by 8.79% in one year.
| Current Share Class | 1.60B |
| Shares Outstanding | 1.60B |
| Shares Change (YoY) | +8.79% |
| Shares Change (QoQ) | +11.30% |
| Owned by Insiders (%) | 1.72% |
| Owned by Institutions (%) | 17.36% |
| Float | 1.19B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 26.14 |
| PS Ratio | 27.38 |
| PB Ratio | 11.97 |
| P/TBV Ratio | 15.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 25.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.57.
| Current Ratio | 2.18 |
| Quick Ratio | 1.95 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31.33 |
Financial Efficiency
Return on equity (ROE) is -89.13% and return on invested capital (ROIC) is -30.85%.
| Return on Equity (ROE) | -89.13% |
| Return on Assets (ROA) | -18.89% |
| Return on Invested Capital (ROIC) | -30.85% |
| Return on Capital Employed (ROCE) | -49.03% |
| Weighted Average Cost of Capital (WACC) | 5.53% |
| Revenue Per Employee | 2.21M |
| Profits Per Employee | -3.58M |
| Employee Count | 136 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 1.08 |
Taxes
In the past 12 months, HKG:2616 has paid 14.54 million in taxes.
| Income Tax | 14.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.77% in the last 52 weeks. The beta is 0.25, so HKG:2616's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -0.77% |
| 50-Day Moving Average | 6.48 |
| 200-Day Moving Average | 6.70 |
| Relative Strength Index (RSI) | 45.44 |
| Average Volume (20 Days) | 9,989,251 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2616 had revenue of HKD 299.99 million and -486.30 million in losses. Loss per share was -0.35.
| Revenue | 299.99M |
| Gross Profit | 57.03M |
| Operating Income | -462.73M |
| Pretax Income | -471.76M |
| Net Income | -486.30M |
| EBITDA | -449.40M |
| EBIT | -462.73M |
| Loss Per Share | -0.35 |
Balance Sheet
The company has 1.07 billion in cash and 387.83 million in debt, with a net cash position of 683.24 million or 0.43 per share.
| Cash & Cash Equivalents | 1.07B |
| Total Debt | 387.83M |
| Net Cash | 683.24M |
| Net Cash Per Share | 0.43 |
| Equity (Book Value) | 686.35M |
| Book Value Per Share | 0.47 |
| Working Capital | 670.99M |
Cash Flow
| Operating Cash Flow | -364.72M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 13.82M |
| Net Borrowing | -9.40M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 19.01%, with operating and profit margins of -154.25% and -162.10%.
| Gross Margin | 19.01% |
| Operating Margin | -154.25% |
| Pretax Margin | -157.26% |
| Profit Margin | -162.10% |
| EBITDA Margin | -149.80% |
| EBIT Margin | -154.25% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2616 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.79% |
| Shareholder Yield | -8.79% |
| Earnings Yield | -5.92% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for HKG:2616 is 14.30, which is 178.21% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 14.30 |
| Price Target Difference | 178.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 59.94% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2616 has an Altman Z-Score of -4.63 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.63 |
| Piotroski F-Score | 3 |